A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Healthy
Interventions: DRUG: Pimodivir|DRUG: Cyclosporine
Sponsor: Janssen-Cilag International NV